Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Eurofins Biopharma Product Testing Sweden AB

Closing information (x1000 DKK)

Closing information 2023/12 2022/12 2021/12
Turnover 45,343 Less Arrow 41,273 Less Arrow 40,804
Financial expenses 1,741 Less Arrow 1,119 Less Arrow 841
Earnings before taxes -13,685 Less Arrow -14,048 Less Arrow -16,846
EBITDA -8,691 Less Arrow -9,584 Less Arrow -12,283
Total assets 24,612 More Arrow 30,845 More Arrow 44,591
Current assets 14,143 More Arrow 17,384 More Arrow 30,691
Current liabilities 14,653 Less Arrow 9,280 More Arrow 10,134
Equity capital -12,539 More Arrow 1,115 More Arrow 13,496
- share capital 67 Equal arrow 67 More Arrow 73
Employees (average) 46 More Arrow 50 More Arrow 60

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency -50.9% More Arrow 3.6% More Arrow 30.3%
Turnover per employee 986 Less Arrow 825 Less Arrow 680
Profit as a percentage of turnover -30.2% Less Arrow -34.0% Less Arrow -41.3%
Return on assets (ROA) -48.5% More Arrow -41.9% More Arrow -35.9%
Current ratio 96.5% More Arrow 187.3% More Arrow 302.9%
Return on equity (ROE) 109.1% Less Arrow -1259.9% More Arrow -124.8%
Change turnover 3,857 Less Arrow 3,775 Less Arrow -3,382
Change turnover % 9% More Arrow 10% Less Arrow -8%
Chg. No. of employees -4 Less Arrow -10 More Arrow 8
Chg. No. of employees % -8% Less Arrow -17% More Arrow 15%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.